Guangzhou Laboratory, a key State facility focused on studying respiratory diseases, is developing a vaccine that could ...
BEIJING -- China's self-developed novel tuberculosis mRNA vaccine started a clinical trial at Beijing Chest Hospital on ...
A WOMAN developed a severe case of the world’s most deadly infection after accidentally being given the wrong vaccine. The ...
On this World TB Day, the emergence of the M72 vaccine shines a much-needed light of hope in our battle against tuberculosis, ...
11 天on MSN
Government health officials detected as many as 719,000 new TB cases during a short, 100-day TB camp held last year, in ...
7 天
Oxford Mail on MSNOxford University trial to test new tuberculosis vaccineThe safety of a new tuberculosis (TB) vaccine is being tested in an Oxford University trial. In partnership with the Coler Lab at Seattle Children's Research Institute, the university has initiated ...
The other headline-making TB vaccine candidate, M72, achieved efficacy of around 50% in phase 2 trials. That vaccine requires two jabs given a month apart, as opposed to the single shot with MTBVAC.
13 天on MSN
As the world marks World Tuberculosis Day, experts are issuing an urgent call for the development of new vaccines against ...
The Star Worldwide (English) on MSN11 天Opinion
Solutions to TB and HIV benefit all of us, North and SouthIn the west of Kenya, near the shores of Lake Victoria, where I come from, a tuberculosis outbreak is no different from one ...
This is part of the department’s goal to reduce TB-related mortality in the state and make it free of the disease.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果